ARRS State of the Art Imaging for Chronic Liver Disease 2021
State of the Art Liver Imaging in Cirrhosis
Full Video Course
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
The second-leading cause of cancer-related mortality in the world and the third most common cause of death among patients with cirrhosis, hepatocellular carcinoma (HCC) develops at a fairly constant rate—approximately 3% per year, regardless of cirrhotic stage. This Online Course covers the imaging of diffuse liver diseases that often result in HCC, as well as the various pitfalls and mimics leading to misinterpretation.
Learning Outcomes and Lectures
After completing this course, the learner should be able to:
- Describe the current Imaging update of diffuse liver diseases.
- Discuss the evolution of LI-RADS with current practice and future perspectives.
- Illustrate various pitfalls and mimics which can hinder the diagnosis of observations in cirrhosis.
- Discuss the use of Gadoxetate Disodium in patients with cirrhosis.
Topics And Speakers:
Speakers and Lectures
- Imaging of Diffuse Liver Diseases—K. Fowler
- LI-RADS: The Past, Present, and Future—C. Sirlin
- Pitfalls and Misdiagnoses in Cirrhosis—K. Elsayes
- Use of Gadoxetate Disodium in Patients with Cirrhosis—V. Chernyak
View the sample recording below
Â

The Osler Vascular Surgery Certifying Exam Oral Review (Extracted 2024)
2020 Mayo Clinic Internal Medicine Board Review
2022 AAFP Family Medicine Board Review Self-Study - 15th Edition
Audio Companion for SESAP 17
The Brigham Update In Hospital Medicine 2020
123Sonography Right Heart MasterClass 2019
Chronic Conditions in Young Adults Transitioning from Pediatric to Adult Care 2019
Gulfcoast Doppler Evaluation of the Fetal Heart
Gulfcoast Ultrasound-Guided Vascular Access
Penn Radiology – Comprehensive Neuroradiology: Best Practices 2017
Gulfcoast Echocardiographic Evaluation of Right Heart Disease (Videos+PDFs)
AIUM Practice Guideline for the Female Pelvis
The Osler Surgical Oncology Certifying Exam Oral Review (Extracted 2024) 




